We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Did you mean Falsified medicines
How to prepare for implementation and compliance of the Safety Features Regulation.
Information relating to the disapplication of falsified medicines under UK Law.
MHRA seeks views on the listing of prescription medicines exempted from the safety feature and non-prescription medicines that must bear the safety feature (MLX387).
A company director and his pharmaceutical manufacturing company were sentenced in court today after pleading guilty to two charges of falsifying data that supported the shelf life of a medicine, adversely affecting its quality in order to obtain a licence...
No evidence of supply or harm to patients
Evaluation of the Department of Health impact assessment for Falsified Medicines Directive 2011/62/EU
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
The Medicines and Healthcare products Regulatory Agency (MHRA), working with law enforcement partners, seized more than 15.5 million doses of illegally traded medicines with a street value of more than £30 million during 2023.
Anyone in Northern Ireland selling medicines to the public via a website must still comply with the requirement to apply the EU common logo.
Information on the implementation of labelling and packaging requirements for medicinal products for human use under the Windsor Framework.
Crescent Pharma Limited has informed the MHRA regarding an error with the European Article Number (EAN) barcode on the cartons of the above-mentioned batches of Pantoprazole 40 mg Gastro-Resistant Tablets distributed by Crescent Pharma Limited.
Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK: you should only access these medicines via a medical prescription.
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
Sets out how to apply the Falsified Medicines Directive (FMD) and the Delegated Regulation to vaccines and other medicines centrally supplied by PHE.
New measures to commence 1 January 2025.
How and when to register updated packaging and information leaflets when new national marketing authorisations have been issued
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.